Teyi Pharmaceutical Group Co Ltd Financial Flexibility Index
Teyi Pharmaceutical Group Co Ltd financial flexibility index. Teyi Pharmaceutical Group Co Ltd (002728) has a Financial Flexibility Index of 0.16x as of December 2025. Free cash flow of CN¥76.63 Million (operating CF CN¥52.94 Million minus capex CN¥23.69 Million) represents 0% of total liabilities (CN¥472.69 Million). Explore capital reinvestment ratio of Teyi Pharmaceutical Group Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Teyi Pharmaceutical Group Co Ltd (2009–2025)
Financial flexibility index of Teyi Pharmaceutical Group Co Ltd from 2009 to 2025. Historical Financial Flexibility Index trend for Teyi Pharmaceutical Group Co Ltd across 17 annual periods. Check Teyi Pharmaceutical Group Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Teyi Pharmaceutical Group Co Ltd Financial Flexibility Index by Year (2009–2025)
Teyi Pharmaceutical Group Co Ltd financial flexibility index by year from 2009 to 2025. Year-by-year free cash flow to debt coverage for Teyi Pharmaceutical Group Co Ltd. For the full cash flow conversion analysis, see Teyi Pharmaceutical Group Co Ltd operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.69x | CN¥324.43 Million | CN¥244.88 Million | CN¥472.69 Million | ▲ +379.6% |
| 2024 | 0.14x | CN¥91.01 Million | CN¥-22.55 Million | CN¥635.94 Million | ▼ -74.8% |
| 2023 | 0.57x | CN¥284.60 Million | CN¥198.56 Million | CN¥501.95 Million | ▲ +40.2% |
| 2022 | 0.40x | CN¥461.92 Million | CN¥371.66 Million | CN¥1.14 Billion | ▼ -11.2% |
| 2021 | 0.46x | CN¥366.39 Million | CN¥256.81 Million | CN¥804.51 Million | ▲ +107.2% |
| 2020 | 0.22x | CN¥258.40 Million | CN¥168.99 Million | CN¥1.18 Billion | ▼ -31.2% |
| 2019 | 0.32x | CN¥352.44 Million | CN¥221.64 Million | CN¥1.10 Billion | ▼ -10.3% |
| 2018 | 0.36x | CN¥340.41 Million | CN¥187.97 Million | CN¥956.39 Million | ▲ +119.7% |
| 2017 | 0.16x | CN¥143.59 Million | CN¥102.96 Million | CN¥886.14 Million | ▼ -57.3% |
| 2016 | 0.38x | CN¥272.15 Million | CN¥101.30 Million | CN¥716.61 Million | ▲ +77.2% |
| 2015 | 0.21x | CN¥170.11 Million | CN¥68.87 Million | CN¥793.78 Million | ▼ -77.1% |
| 2014 | 0.94x | CN¥84.33 Million | CN¥57.35 Million | CN¥89.96 Million | ▼ -19.4% |
| 2013 | 1.16x | CN¥120.28 Million | CN¥74.23 Million | CN¥103.40 Million | ▼ -12.5% |
| 2012 | 1.33x | CN¥136.70 Million | CN¥104.50 Million | CN¥102.88 Million | ▼ -1.1% |
| 2011 | 1.34x | CN¥77.53 Million | CN¥69.81 Million | CN¥57.71 Million | ▲ +119.2% |
| 2010 | 0.61x | CN¥50.21 Million | CN¥46.92 Million | CN¥81.92 Million | ▲ +101.2% |
| 2009 | 0.30x | CN¥26.34 Million | CN¥22.32 Million | CN¥86.47 Million | — |